Che-1 gene silencing induces osteosarcoma cell apoptosis by inhibiting mutant p53 expression

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• The transcriptional cofactor Che-1 (also known as RNA polymerase II cofactor) is implicated in various cancers, including breast cancer and multiple myeloma.
• Che-1's role in regulating mutant p53 expression, a common factor in tumorigenesis, highlights its potential significance in cancer development.

Purpose of the Study:

• To investigate the specific mechanisms by which Che-1 influences osteosarcoma (OS) cell growth.
• To determine the therapeutic potential of targeting Che-1 in osteosarcoma.

Main Methods:

• Quantitative analysis of Che-1 expression in OS cells versus normal osteoblasts.
• Cell proliferation and apoptosis assays (MTT, flow cytometry) following Che-1 depletion via siRNA.
• Chromatin immunoprecipitation (ChIP) to assess Che-1 binding to the p53 promoter.
• Western blot analysis to evaluate mutant p53 protein levels.

Main Results:

• Che-1 is significantly overexpressed in multiple osteosarcoma cell lines compared to normal osteoblasts.
• Depletion of Che-1 using siRNA suppressed proliferation and induced apoptosis in MG-63 and U2OS osteosarcoma cells.
• Che-1 was confirmed to bind the p53 promoter in cells with mutant p53, and its depletion led to decreased mutant p53 expression.
• The study demonstrated that Che-1 loss inhibits osteosarcoma cell proliferation and promotes apoptosis by reducing mutant p53 levels.

Conclusions:

• Che-1 plays a critical role in promoting osteosarcoma cell proliferation and survival.
• The mechanism involves Che-1's regulation of mutant p53 expression.
• Targeting Che-1 through silencing presents a promising therapeutic strategy for osteosarcoma treatment.